Compatibility of nebuliser solution combinations

22 June 2022Mixing nebuliser solutions is often done but rarely licensed. Compatibility of these solutions have been studied and are outlined below, along with a handy tool

Safety in Lactation: Mucolytics and other drugs for cystic fibrosis

18 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. There is no evidence to support…
Search Articles

Refrigerated Storage

Pulmozyme Roche Products Ltd

Roche Products Ltd
Nebuliser solution, 2500units/2.5ml

In the event of an inadvertent temperature excursion the following data may be used:
A single brief exposure to elevated temperatures (less than or equal to 24 hours at up to 30°C) does not affect product stability.
Please also refer to the manufacturer’s product literature for recommended storage information at

See above
See above

Please also note that stability data is updated when new information becomes evident and in that regard, you should contact Roche on a case-by-case basis for the most up to date information relating to stability of our products outside of the licensed conditions.

28 September 2020
London MI Service

Lactation Safety Information

No published evidence of safety
Low levels anticipated in milk due to the drug’s properties and likely to be degraded in infant’s GI tract
4 June 2017